
X
UK pharma concedes defeat on NHS drug cost controls
https://pharmaphorum.com/news/uk-pharma-concedes-defeat-nhs-drug-cost-controls/
Simon Stevens hails success in negotiating with pharma companies on price and data, and has defended NHS England’s record in promoting innovative medicines.
Gaining access to ultra-orphan drugs could become much more difficult.
New cost-capping and delaying measures will further restrict access to new medicines say pharma and patient groups.
NHS England and NICE are attempting to reduce budget impact of drugs.
What could be the impact of proposed new ‘budget impact threshold’ for drugs?